Skip to main content

Table 4 Comparison of postoperative pathological upgrade risks based on endometrial sampling methods

From: Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy

Endometrial sampling pathology Upgrade on final pathology Endometrial sampling method P
D&C (n = 100) Aspiration biopsy (n = 150)
Hyperplasia without atypia No 49 (87.5) 44 (71.0) 0.028
Yes 7 (12.5) 18 (29.0)
Atypical hyperplasia No 30 (68.2) 51 (58.0) 0.255
Yes 14 (31.8) 37 (42.0)
Total No 79 (79.0) 95 (63.3) 0.008
Yes 21 (21.0) 55 (36.7)
  1. Data are n (%) unless otherwise specified
  2. D&C Dilatation and curettage